NuVasive (NUVA) Tops Q1 EPS by 2c

Go back to NuVasive (NUVA) Tops Q1 EPS by 2c

NuVasive (NUVA) PT Raised to $80 at Needham & Company

May 6, 2021 6:58 AM EDT

Needham & Company analyst Mike Matson raised the price target on NuVasive (NASDAQ: NUVA) to $80.00 (from $70.00) while maintaining a Buy rating.

The analyst commented, "NUVA's 1Q21 revenue and EPS beat consensus and revenue growth improved from the prior quarter. Adjusting for comps, we... More